Event

Suso Platero

PhD
Janssen Pharmaceuticals

Samjot Singh. Dhillon

MD
Roswell Park Cancer Institute

Catalina Perdomo

PhD
Boston University School of Medicine

Christopher Moy

PhD
Janssen Pharmaceuticals

Marc Elliot. Lenburg

Ph.D.
Boston Univ School of Med;Boston University;Boston University School of Medicine

Christopher Stevenson

PhD
Janssen Pharmaceuticals

Gang Liu

Ph.D.
Boston University School of Medicine

Sarah Mazzilli

PhD
Boston University School of Medicine

Anna M. Tassinari

PhD
Boston University

William E. Johnson

PhD
Boston University School of Medicine

Sherry Zhang

B.S.
Boston University School of Medicine

Avrum Spira

MD, MSc
Boston Univ Medical Campus;Boston University;Boston University School of Medicine;Boston University School of Medicine (on behalf of the DECAMP investigators)

David Jenkins

B.S.
Boston University

Jennifer Beane

Ph.D.
Boston University Medical Center;Boston University School of Medicine

Michael Schaffer

PhD
Janssen Pharmaceuticals

Hanqiao Liu

B.S.
Boston University School of Medicine

Jessica Vick

M.S.
Boston University School of Medicine

Mary Reid

PhD
Roswell Park Cancer Institute

Joshua David. Campbell

Ph.D.
Boston University School of Medicine

Mary Beth Pine

B.A.
Roswell Park Cancer Institute

Bronchial Premalignant Lesions Have Distinct Molecular Subtypes Associated with Future Histologic Progression